LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.22 | 771.67 | 1917 | 4299 | 0.4459 | 0.4437 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 38.22 | 771.67 | 2116 | 4299 | 0.4921 | 0.5024 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.44 | 771.67 | 2022 | 4738 | 0.4267 | 0.4447 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 40.44 | 771.67 | 2180 | 4738 | 0.4601 | 0.4868 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.67 | 771.67 | 2111 | 5155 | 0.4095 | 0.4438 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 42.67 | 771.67 | 2286 | 5155 | 0.4434 | 0.4864 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.89 | 771.67 | 2180 | 5541 | 0.3934 | 0.4407 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 44.89 | 771.67 | 2377 | 5541 | 0.4290 | 0.4852 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.11 | 771.67 | 2301 | 5941 | 0.3873 | 0.4492 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 47.11 | 771.67 | 2531 | 5941 | 0.4260 | 0.4969 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.33 | 771.67 | 2378 | 6392 | 0.3720 | 0.4462 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 49.33 | 771.67 | 2635 | 6392 | 0.4122 | 0.4957 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.55 | 771.67 | 2489 | 6829 | 0.3644 | 0.4510 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 51.55 | 771.67 | 2715 | 6829 | 0.3975 | 0.4917 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 771.67 | 2572 | 7256 | 0.3545 | 0.4511 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 53.77 | 771.67 | 2894 | 7256 | 0.3988 | 0.5051 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.99 | 771.67 | 2713 | 7690 | 0.3528 | 0.4609 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 55.99 | 771.67 | 3064 | 7690 | 0.3984 | 0.5155 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 771.67 | 2897 | 8085 | 0.3583 | 0.4774 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 58.21 | 771.67 | 3193 | 8085 | 0.3949 | 0.5205 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.44 | 771.67 | 3034 | 8530 | 0.3557 | 0.4843 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 60.44 | 771.67 | 3349 | 8530 | 0.3926 | 0.5272 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.66 | 771.67 | 3196 | 8978 | 0.3560 | 0.4939 | MN20160304_L01 | H17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 62.66 | 771.67 | 3504 | 8978 | 0.3903 | 0.5332 | MN20160304_L01 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 1.7783 | 64.88 | 771.67 | 3309 | 9447 | 0.3503 | 0.4961 | MN20160304_L01 | H17 |